<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:24.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.itxtrst
{mso-style-name:itxtrst;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>This article is a rational approach to PSA testing in light of the recent controversy.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>I believe that as PCa patients & survivors we should ensure that the usefulness of PSA testing be reinforced with the “men in our life”.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen Tolhurst<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Co-facilitator PCCN Waterloo<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><h1>Letter: Don't dismiss this prostate test for all<o:p></o:p></h1><div><div><div><p>EDITOR: As physicians practicing in Wausau and north-central WI for over twenty years, we are concerned by new recommendations of the U.S. Preventive Services Task Force against prostate-specific antigen testing.<o:p></o:p></p><p>These recommendations do a disservice to men around the country, particularly those with a higher risk of the disease -- including those with a family history, African <a href="http://www.wausaudailyherald.com/article/20111206/WDH06/112060548/Letter-Don-t-dismiss-prostate-test-all" id=itxthook0><span class=itxtrst><span style='color:darkgreen'>American</span></span></a> men, those who are underinsured and those with limited access to health care.<o:p></o:p></p><p>The American Urological Association believes the best decisions regarding prostate cancer testing come from individualized discussions between a man and his physician -- no single standard applies to all men. The PSA test has limitations, but when used and interpreted appropriately, the test provides valuable information for diagnosis, pre-treatment staging, risk assessment and monitoring of prostate cancer.<o:p></o:p></p><p>It would be barbaric to universally dismiss the PSA test before a suitable alternative to prostate cancer diagnosis is available. There are many men in this community who say that a PSA test saved their life.<o:p></o:p></p><p>Approximately 130 men are diagnosed and treated for prostate cancer at Wausau Aspirus Hospital each year. Before PSA testing was available, most men diagnosed with prostate cancer had more advanced disease that was not curable.<o:p></o:p></p><p>Today, the majority of men are diagnosed earlier, with curable cancer. This earlier cancer detection is due to PSA screening. Not all men with prostate cancer should be treated, and the method of treatment must be individualized.<o:p></o:p></p><p>Benjamin S. Battino, M.D.,<o:p></o:p></p><p>submitted on behalf of the physicians of Urology Specialists of Wisconsin and the Aspirus Regional Cancer Center,<o:p></o:p></p><p>Wausau<o:p></o:p></p></div></div></div><p class=MsoNormal><o:p> </o:p></p><p>__________ Information from ESET Smart Security, version of virus signature database 6692 (20111207) __________<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p>The message was checked by ESET Smart Security.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p><a href="http://www.eset.com">http://www.eset.com</a><o:p></o:p></p></div> <BR><BR>__________ Information from ESET Smart Security, version of virus signature database 6693 (20111208) __________<BR><BR>The message was checked by ESET Smart Security.<BR><BR><A HREF="http://www.eset.com">http://www.eset.com</A><BR> </body></html>